US appeals court affirms Plavix patent, blocking generic clopidogrel
This article was originally published in Scrip
Executive Summary
The US Court of Appeals for the Federal Circuit has ruled in favour of Bristol-Myers Squibband Sanofi-Aventisin a patent infringement battle withApotex, and affirmed a lower court ruling that said that Sanofi-Aventis's compound patent for Plavix (clopidogrel bisulfate) is valid.